Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPMorgan Japanese Regulatory News (JFJ)

Share Price Information for JPMorgan Japanese (JFJ)

Share Price is delayed by 15 minutes
Get Live Data
804.00    -30.00 (-3.60%)
Bid:
833.00
Ask:
731.00
Spread: -102.00 (-12.245%)
Market Cap: £1.23b
JFJ Live PriceLast checked at - London Stock Exchange

Intraday JPMorgan Japanese Share Chart

Appointment of Director

4 Jun 2025 07:00

RNS Number : 2990L
JPMorgan Japanese Inv. Trust PLC
04 June 2025
 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN JAPANESE INVESTMENT TRUST PLC

(the 'Company')

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 549300JZW3TSSO464R15

Information disclosed in accordance with LR 9.6.11 and LR 9.6.13

 

The Board of JPMorgan Japanese Investment Trust plc is pleased to announce the appointment of Mr. Takashi Maruyama as a Non-Executive Director of the Company with effect from 1st October 2025. He will replace Mr. George Olcott, who is due to step down from the Board at the end of his tenure in January 2026.

Mr. Takashi Maruyama is the former Managing Executive Officer and Chief Investment Officer (CIO) of Asset Management One Co., Ltd., one of Japan's largest asset management firms with over USD 500 billion in assets under management. He held this role from April 2022 until March 2025.

He brings with him more than three decades of experience in the global investment management industry. Prior to joining Asset Management One, Mr. Maruyama served as CIO at FIL Investments (Japan) Ltd. (Fidelity International) from 2015. Before that, he held senior leadership positions at Nikko Asset Management, including Head of Japanese Equity and Alternative Investments. His earlier career includes roles at DIAM USA and the Industrial Bank of Japan (IBJ), where he began his career in portfolio management.

Mr. Maruyama has been recognized for his leadership in the industry, including being named one of the "Top 10 Chief Investment Officers in Asia" by CEO Insights Asia in 2023.

He holds a degree in Master of Science in Engineering, and is fluent in both Japanese and English, enabling him to bridge insights across markets and cultures.

Mr. Maruyama is based in Japan and currently owns no shares in the Company.

 

No further information is to be disclosed in respect of paragraphs 9.6.13(2) - (6) of the Listing Rules for Takashi Maruyama.

3 June 2025

For further information, please contact:

 

Priyanka Vijay Anand

JPMorgan Funds Limited - Company Secretary

Telephone 0207 742 4000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFVTRLIVIIE
Date   Source Headline
23rd Jun 202610:43 amRNSNet Asset Value(s)
23rd Jun 20269:29 amRNSTransaction in Own Shares
22nd Jun 202611:00 amRNSGearing Announcement
22nd Jun 202610:30 amRNSNet Asset Value(s)
22nd Jun 202610:09 amRNS-RUpdate note from QuotedData
19th Jun 20265:04 pmRNSTransaction in Own Shares
19th Jun 202611:03 amRNSNet Asset Value(s)
19th Jun 20269:42 amRNSHolding(s) in Company
18th Jun 20265:04 pmRNSTransaction in Own Shares
18th Jun 202610:26 amRNSNet Asset Value(s)
17th Jun 20264:57 pmRNSTransaction in Own Shares
17th Jun 202611:11 amRNSNet Asset Value(s)
16th Jun 20265:00 pmRNSTransaction in Own Shares
16th Jun 202611:03 amRNSNet Asset Value(s)
15th Jun 20265:26 pmRNSTransaction in Own Shares
15th Jun 202611:19 amRNSGearing Announcement
15th Jun 202610:59 amRNSNet Asset Value(s)
12th Jun 20265:17 pmRNSTransaction in Own Shares
12th Jun 202611:57 amRNSNet Asset Value(s)
12th Jun 202610:22 amRNSTen Largest Investments
11th Jun 20265:27 pmRNSTransaction in Own Shares
11th Jun 202610:58 amRNSNet Asset Value(s)
10th Jun 20265:01 pmRNSTransaction in Own Shares
10th Jun 202611:53 amRNSNet Asset Value(s)
9th Jun 20265:08 pmRNSTransaction in Own Shares
9th Jun 202610:47 amRNSNet Asset Value(s)
8th Jun 202610:58 amRNSGearing Announcement
8th Jun 202610:42 amRNSNet Asset Value(s)
5th Jun 20264:56 pmRNSTransaction in Own Shares
5th Jun 202611:26 amRNSNet Asset Value(s)
4th Jun 20265:08 pmRNSTransaction in Own Shares
4th Jun 202611:01 amRNSNet Asset Value(s)
3rd Jun 20265:03 pmRNSTransaction in Own Shares
3rd Jun 202610:58 amRNSNet Asset Value(s)
2nd Jun 202611:12 amRNSNet Asset Value(s)
1st Jun 202611:50 amRNSGearing Announcement
1st Jun 202611:18 amRNSNet Asset Value(s)
1st Jun 202610:39 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSHalf-year Financial Report
29th May 20265:05 pmRNSTransaction in Own Shares
29th May 202610:41 amRNSNet Asset Value(s)
28th May 20265:21 pmRNSTransaction in Own Shares
28th May 202610:43 amRNSNet Asset Value(s)
27th May 20264:55 pmRNSTransaction in Own Shares
27th May 202611:20 amRNSNet Asset Value(s)
26th May 20264:58 pmRNSTransaction in Own Shares
26th May 20261:59 pmRNSGearing Announcement
26th May 202612:12 pmRNSNet Asset Value(s)
22nd May 20265:22 pmRNSTransaction in Own Shares
22nd May 202611:46 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.